Dr. Sulaiman Al Habib Medical Services Group (Sulaiman Al Habib) reported a net profit of SAR 557 million in Q1 2025, an increase of 1%, compared to SAR 551 million in Q1 2024.
Item | Q1 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 2,521.41 | 3,157.78 | 25.2 % |
Gross Income | 877.33 | 1,028.31 | 17.2 % |
Operating Income | 556.07 | 625.93 | 12.6 % |
Net Income | 550.95 | 557.01 | 1.1 % |
Average Shares | 350.00 | 350.00 | - |
Earnings Per Share before unusual items (Riyal) | 1.57 | 1.59 | 1.1 % |
EPS (Riyal) | 1.57 | 1.59 | 1.1 % |
Item | Q4 2024 | Q1 2025 | Change |
---|---|---|---|
Revenues | 3,128.85 | 3,157.78 | 0.9 % |
Gross Income | 996.81 | 1,028.31 | 3.2 % |
Operating Income | 624.13 | 625.93 | 0.3 % |
Net Income | 613.77 | 557.01 | (9.2 %) |
Average Shares | 350.00 | 350.00 | - |
Earnings Per Share before unusual items (Riyal) | 1.63 | 1.59 | (2.3 %) |
EPS (Riyal) | 1.75 | 1.59 | (9.2 %) |
This was propelled by Q1 2025 earnings before interest, taxes, depreciation and amortization (EBITDA), which increased by 19.81% to SAR 816.05 million, compared to SAR 681.12 million last year. EBITDA margin reached 25.84% from 27.01% a year earlier.
The company also cited revenue growth. However, fixed operating costs associated with recent strategic expansions temporarily impacted profit margins. These expansions are still undergoing gradual revenue growth and are expected to progressively reach optimal operational capacity.
On a sequential basis, net earnings dropped 9.2% from SAR 613.77 million in Q4 2024. This was primarily attributed to revenue seasonal factors, along with the impact of certain non-recurring items, including a gain of SAR 43.68 million recognized from the disposal of an investment stake in an associate in Q4 2024.
Total shareholders’ equity, after minority interest, stood at SAR 7.29 billion as of March 31, 2025, compared to SAR 6.63 billion a year earlier.
Attached Documents:
Be the first to comment
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments Analysis: